Determinants of pulmonary hypertension in patients with beta-thalassemia major and normal ventricular function

Acta Haematologica

Volumn 128, Issue 2, 2012, Pages 124-129

  Vlahos, Antonios P ^a   Koutsouka, Frideriki P ^a   Papamichael, Nikolaos D ^b   Makis, Alexandros ^a   Baltogiannis, Giannis G ^a   Athanasiou, Eleni ^b   Chaliasos, Nikolaos ^a   Bourantas, Konstantinos L ^a   Kolettis, Theofilos M ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b Arta General Hospital   (Greece)

Author keywords

Thalassemia major; Chelation therapy; Ferritin; Hemochromatosis; Pulmonary hypertension

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADULT; ARTICLE; CHELATION THERAPY; CLINICAL ARTICLE; ECHOCARDIOGRAPHY; FEMALE; FERRITIN BLOOD LEVEL; HEART VENTRICLE FUNCTION; HUMAN; IRON OVERLOAD; MALE; MORBIDITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; CASE-CONTROL STUDIES; CHELATING AGENTS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED;

EID: 84864207280     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000338825     Document Type: Article

References (23)

1. Aessopos A, Farmakis D: Pulmonary hypertension in beta-thalassemia. Ann NY Acad Sci 2005; 1054: 342-349.
2. Grisaru D, Rachmilewitz EA, Mosseri M, Gotsman M, Lafair JS, Okon E, Goldfarb A, Hasin Y: Cardiopulmonary assessment in beta-thalassemia major. Chest 1990; 98: 1138-1142. (Pubitemid 20381277)
3. Du ZD, Roguin N, Milgram E, Saab K, Koren A: Pulmonary hypertension in patients with thalassemia major. Am Heart J 1997; 134: 532-537. (Pubitemid 27431260)
4. Aessopos A, Farmakis D, Hatziliami A, Fragodimitri C, Karabatsos F, Joussef J, Mitilineou E, Diamanti-Kandaraki E, Meletis J, Karagiorga M: Cardiac status in well-treated patients with thalassemia major. Eur J Haematol 2004; 73: 359-366. (Pubitemid 39349917)
5. Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M: Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest 2005; 127: 1523-1530. (Pubitemid 46218775)
6. Farmakis D, Aessopos A: Pulmonary hypertension associated with hemoglobinopathies: prevalent but overlooked. Circulation 2011; 123: 1227-1232.
7. Aessopos A, Farmakis D, Taktikou H, Loukopoulos D: Doppler-determined peak systolic tricuspid pressure gradient in persons with normal pulmonary function and tricuspid regurgitation. J Am Soc Echocardiogr 2000; 13: 645-649. (Pubitemid 30485045)
8. Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G: Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009; 30: 2493-2537.
9. Alymara V, Bourantas D, Chaidos A, Bouranta P, Gouva M, Vassou A, Tzouvara E, Bourantas KL: Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone. Hematol J 2004; 5: 475-479. (Pubitemid 40045280)
10. Derchi G, Fonti A, Forni GL, Galliera EO, Cappellini MD, Turati F, Policlinico OM: Pulmonary hypertension in patients with thalassemia major. Am Heart J 1999; 138: 384. (Pubitemid 29379695)
11. Farmaki K, Tzoumari I, Pappa C: Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications. Blood Cells Mol Dis 2011; 47: 33-40.
12. Trachtenberg F, Vichinsky E, Haines D, Pakbaz Z, Mednick L, Sobota A, Kwiatkowski J, Thompson AA, Porter J, Coates T, Giardina PJ, Olivieri N, Yamashita R, Neufeld EJ: Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol 2011; 86: 433-436.
13. Kolnagou A, Kleanthous M, Kontoghiorghes GJ: Efficacy, compliance and toxicity factors are affecting the rate of normalization of body iron stores in thalassemia patients using the deferiprone and deferoxamine combination therapy. Hemoglobin 2011; 35: 186-198.
14. Telfer PT, Prestcott E, Holden S, Walker M, Hoffbrand AV, Wonke B: Hepatic iron concentration combined with long-term monitoring of serum ferritin to predict complications of iron overload in thalassaemia major. Br J Haematol 2000; 110: 971-977.
15. Atichartakarn V, Likittanasombat K, Chuncharunee S, Chandanamattha P, Worapongpaiboon S, Angchaisuksiri P, Aryurachai K: Pulmonary arterial hypertension in previously splenectomized patients with beta-thalassemic disorders. Int J Hematol 2003; 78: 139-145. (Pubitemid 37021954)
16. Hamdy AM, Zein El-Abdin MY, Abdel-Hafez MA: Right ventricular function in patients with beta thalassemia: relation to serum ferritin level. Echocardiography 2007; 24: 795-801. (Pubitemid 47346735)
17. Hagar RW, Morris CR, Vichinsky EP: Pulmonary hypertension in thalassaemia major patients with normal left ventricular systolic function. Br J Haematol 2006; 133: 433-435.
18. Esposito BP, Breuer W, Sirankapracha P, Pootrakul P, Hershko C, Cabantchik ZI: Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 2003; 102: 2670-2677. (Pubitemid 37193611)
19. Cabantchik ZI, Breuer W, Zanninelli G, Cianciulli P: LPI-labile plasma iron in iron overload. Best Pract Res Clin Haematol 2005; 18: 277-287. (Pubitemid 40298370)
20. Cheung YF, Chan GC, Ha SY: Arterial stiffness and endothelial function in patients with beta-thalassemia major. Circulation 2002; 106: 2561-2566. (Pubitemid 35340692)
21. Rabinovitch M: Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 2008; 118: 2372-2379. (Pubitemid 351949764)
22. Duffy SJ, Biegelsen ES, Holbrook M, Russell JD, Gokce N, Keaney JF Jr, Vita JA: Iron chelation improves endothelial function in patients with coronary artery disease. Circulation 2001; 103: 2799-2804. (Pubitemid 32550067)
23. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ: Cardiovascular T 2-star (T 2 * ) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22: 2171-2179. (Pubitemid 33139463)